U.S. market Closed. Opens in 5 hours 5 minutes

MREO | Mereo BioPharma Group plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue10.00M1.51M36.46M393.00K-122.00KN/A-3.29MN/A
Cost of Revenue2.57M936.00K17.91M16.35M23.61M22.70M31.32M24.56M
Gross Profit7.43M571.00K18.56M-15.95M-23.73M-22.70M-34.61M-24.56M
Operating Expenses34.56M44.51M39.49M21.22M15.91M12.50M41.60M11.62M
Selling, General & Admin18.42M19.54M15.93M21.22M15.91M12.50M10.28M11.62M
Research & Development17.42M24.96M23.56M-16.35M-23.61M22.70M31.32M24.56M
Other Operating Expenses-10.00K811.00KN/AN/AN/AN/A-293.33K-24.56M
Operating Income-28.42M-43.57M-20.94M-37.57M-39.52M-35.21M-45.30M-36.18M
Other Expenses / Income-2.11M7.48M35.18M-128.88M-1.60M-43.86K-1.72M2.46M
Before Tax Income-30.00M-36.09M14.24M-166.45M-41.12M-37.31M-46.95M-33.72M
Income Tax Expenses-532.00K-1.90M1.52M-2.82M-6.27M-5.28M-8.15M-5.33M
Net Income-29.47M-34.20M12.72M-163.63M-34.84M-32.03M-38.80M-28.39M
Interest Expenses2.88M3.36M4.00M6.38M3.50M2.36M497.17K179.76K
Basic Shares Outstanding659.45M603.20M527.82M337.72M89.34M14.23M13.80M8.96M
Diluted Shares Outstanding659.45M603.20M555.28M338.95M89.42M14.23M13.80M8.96M
EBITDA-23.95M-42.06M-20.31M-37.52M-37.56M-34.86M-46.42M-35.77M
EBITDA Margin-239.54%-2,791.11%-55.71%-9,548.35%30,789.34%0.00%1,412.90%0.00%
EBIT-27.12M-32.73M18.24M-160.07M-37.62M-34.95M-46.45M-33.54M
EBIT Margin-271.17%-2,172.00%50.03%-40,729.52%30,837.70%0.00%1,414.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙